CAC
TVGNW icon

Cowen and Company’s Tevogen Inc. Warrant TVGNW Stock Holding History

Cowen and Company’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,400
Closed -$100 – 693
2022
Q4 		$100 Buy
+13,400
New +$390 ﹤0.01% 665
2022
Q3 		– Sell
-12,000
Closed -$2K – 781
2022
Q2 		$2K Buy
+12,000
New +$2.83K ﹤0.01% 621

Other funds holding TVGNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Cowen and Company's TVGNW Position: Q1 2023 in Review

Cowen and Company sold out of Tevogen Inc. Warrant (TVGNW) in Q1 2023, closing a stake of 13,400 shares — an estimated $100 sold.

Cowen and Company first reported a position in TVGNW in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 55 funds tracked by Wall St. Rank hold TVGNW as of Q1 2023.

  • Cowen and Company reported no remaining Tevogen Inc. Warrant position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 13,400 Tevogen Inc. Warrant shares in Q1 2023, an estimated $100.
  • Cowen and Company first reported a position in Tevogen Inc. Warrant in Q2 2022 and held it in 2 quarters.
  • Cowen and Company's Tevogen Inc. Warrant position peaked at $2K in Q2 2022.
  • 55 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.